17 / 26
Page 72
Journal of Infectious Diseases and Treatment
ISSN: 2472-1093
7
t h
E u r o s c i c o n C o n f e r e n c e o n
Clinical Pathology
and Epidemiology
F e b r u a r y 2 7 - 2 8 , 2 0 1 9
P r a g u e , C z e c h R e p u b l i c
Clinical Pathology & Epidemiology 2019
Introduction:
Cervical cancer is the most frequent cancer among women in Senegal. However, there are few data concerning the
HPV types inducing neoplasia and cervical cancers and their prevalence, in the general population of Senegal
Aims:
The aim of this study is to determine the prevalence of HPV infection in Senegalese women aged from 18 years and older.
Materials & Methods:
A study was performed on 498 cervix samples collected from healthy women aged 18 and older in Dakar.
438 other samples were collected from three other regions, Thiès, Saint Louis and Louga. The samples were screened for 21 HPV
genotypes using an HPV type-specific E7 PCR bead-based multiplex genotyping assay (TS-MPG) which is a laboratory-developed
method for the detection of HPV.
Results:
The prevalence for probable high risk/high risk HPV (pHR/HR-HPV) in the region of Dakar was 20.68%. HPV 52 (3.21%)
was the most prevalent HPV type, followed by HPV 16 (3.01%) and HPV 31 (3.01%). In the regions of Thiès, Louga and Saint Louis,
the prevalence for pHR/HR-HPV was 29.19%, 23.15% and 20%, respectively
Conclusion:
The study revealed the specificity of the HR-HPV prevalence in Dakar and other regions of Senegal. The patterns
differs from the one observed in the other regions of the world and raise the issue of the development of vaccination program
in the country. Such a program should take into account the real HPV prevalence for an effective protection of HPV-associated
diseases.
seydou27@hotmail.comHuman papillomavirus infection in genital women
in four regions of Senegal
El Hadji Seydou Mbaye
1,2,3
, Tarik Gheit
1
, Ahmadou Dem
3
,
Sandrine McKay-Chopin
1
, Ndeye Coumba Toure-Kane
2
,
Souleymane Mboup
2
, Massimo Tommasino
1
, Bakary S Sylla
1
and Cheikh Saad Bouh Boye
2
1
International Agency for Research on Cancer (IARC/WHO), Lyon, France
2
Aristide Le Dantec Hospital, Senegal
3
Cancer Institute, Aristide Le Dantec Hospital, Senegal
J Infec Dis Treat 2019, Volume: 5
DOI: 10.21767/2472-1093-C1-009